500 related articles for article (PubMed ID: 16409558)
1. Continuous glucose monitoring and closed-loop systems.
Hovorka R
Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
[TBL] [Abstract][Full Text] [Related]
2. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop insulin delivery - what lies between where we are and where we are going?
Steil GM; Rebrin K
Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
[TBL] [Abstract][Full Text] [Related]
4. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
6. Neonatal diabetes and insulin pump therapy.
Beardsall K; Pesterfield CL; Acerini CL
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
[TBL] [Abstract][Full Text] [Related]
7. Controlled drug delivery in the treatment of diabetes mellitus.
Irsigler K; Kritz H; Lovett RG
Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
[TBL] [Abstract][Full Text] [Related]
8. Insulin pumps and glucose regulation.
Thompson JS; Duckworth WC
World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
[TBL] [Abstract][Full Text] [Related]
9. [From external to implantable insulin pump, can we close the loop?].
Renard E; Costalat G; Bringer J
Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
[TBL] [Abstract][Full Text] [Related]
10. [Implantable artificial endocrine pancreas].
Shichiri M; Nishida K; Sakakida M; Araki E
Nihon Rinsho; 2002 Sep; 60 Suppl 9():620-4. PubMed ID: 12387060
[No Abstract] [Full Text] [Related]
11. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
12. Sensor-augmented pump therapy in type 1 diabetes.
Weinzimer SA; Tamborlane WV
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):118-22. PubMed ID: 18316945
[TBL] [Abstract][Full Text] [Related]
13. A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method.
Gopakumaran B; Duman HM; Overholser DP; Federiuk IF; Quinn MJ; Wood MD; Ward WK
Artif Organs; 2005 Aug; 29(8):599-607. PubMed ID: 16048475
[TBL] [Abstract][Full Text] [Related]
14. Designing the modern pump: engineering aspects of continuous subcutaneous insulin infusion software.
Welsh JB; Vargas S; Williams G; Moberg S
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S37-42. PubMed ID: 20515305
[TBL] [Abstract][Full Text] [Related]
15. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
16. The glucose sensor: the missing link in diabetes therapy.
Pfeiffer EF
Horm Metab Res Suppl; 1990; 24():154-64. PubMed ID: 2272621
[TBL] [Abstract][Full Text] [Related]
17. Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop.
Hanaire H
Diabetes Metab; 2006 Dec; 32(5 Pt 2):534-8. PubMed ID: 17130814
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in continuous glucose monitoring.
Freckmann G; Kalatz B; Pfeiffer B; Hoss U; Haug C
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S347-57. PubMed ID: 11460583
[TBL] [Abstract][Full Text] [Related]
19. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
[TBL] [Abstract][Full Text] [Related]
20. A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.
Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Gómez EJ; Hernando ME
Diabetes Technol Ther; 2010 Feb; 12(2):95-104. PubMed ID: 20105038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
